昌興國際(00803.HK):黃炳均辭任董事會主席
格隆匯12月18日丨昌興國際(00803.HK)公佈,黃炳均先生已辭任執行董事、授權代表,以投放更多時間於其個人業務事務上,於黃先生辭任執行董事後,彼不再為董事會主席;聶巧明先生及馬鑫先生因個人事務辭任執行董事;趙根先生因其他業務辭任獨立非執行董事;關貴森先生因其他業務辭任獨立非執行董事席;孫瑞女士因彼需要更多精力專注處理其他個人事務已辭任公司的公司祕書;公司行政總裁謝強明先生已獲委任為主席及提名委員會主席;及獨立非執行董事閆曉田先生已獲委任為第16部授權代表、聯交所授權代表、審核委員會主席、提名委員會成員及薪酬委員會成員兼主席,自2020年12月18日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.